Endometrial CancerNCT05737745
FitEx for Endometrial Cancer Survivors: Initial Efficacy
A study testing Self-monitoring, Group-dynamics and Weekly virtual sessions- Standard in people with Endometrial Cancer and Obesity, run by Carilion Clinic at 1 site in United States.
Trial summary
The goal of this clinical trial is to compare physical activity outcomes between endometrial cancer survivors randomized to 1 of 3 conditions: 1) usual care, 2) FitEx, 3) FitEx+yoga. Survivors randomized to FitEx groups will recruit ~3 support team members to complete the intervention with them. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Endometrial Cancer, Obesity, Sedentary Behavior
- What is being tested?
- Self-monitoring, Group-dynamics and Weekly virtual sessions- Standard
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 111 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Feb 2023to 20 Jun 2024
- Phase
- Interventional
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- SURIVIVOR
- Diagnosed with early stage (I-II) endometrial cancer, any histology
- Received cancer care at Carilion Clinic after 1/1/2010
- At least 18 years of age
- Have adequate comprehension (reading and writing) of the English language
- Have a BMI ≥ 30 kg/m^2 at screening
Show all 16Show fewer
- Have stable internet access or access to a smartphone with internet capabilities
- Meet the requirements of the Physical Activity Readiness Questionnaire(PARQ)
- Have the capacity to provide informed consent and are willing to provide informed consent
- SUPPORT TEAM--
- Were identified by a participant with endometrial cancer as a member of their support system
- Are at least 18 years of age
- Have adequate comprehension (reading and writing) of the English language
- Have stable internet access or access to a smartphone with internet capabilities
- Meet the requirements of the Physical Activity Readiness Questionnaire (PARQ)
- Have the capacity to provide informed consent and are willing to provide informed consent
Who cannot join
- SURVIVOR
- Recurrent endometrial cancer
- Meeting physical activity guidelines set forth by the American Cancer Society at screening (greater than 150 minutes/week of moderate physical activity, or greater than 75 minutes/week of vigorous physical activity)
- SUPPORT TEAM: Have functional limitations requiring a walker, wheelchair, scooter, or other walking aid which limits their capacity to engage in the intervention safely
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Initial Efficacy of FitEx for Endometrial Cancer Survivors: A Pilot Randomized Controlled Trial of a Walking Promotion Program With or Without Yoga
The goal of this clinical trial is to compare physical activity outcomes between endometrial cancer survivors randomized to 1 of 3 conditions: 1) usual care, 2) FitEx, 3) FitEx+yoga. Survivors randomized to FitEx groups will recruit ~3 support team members to complete the intervention with them. The main question[s] it aims to answer are:
- Do FitEx groups undertake more physical activity than the usual care group?
- Are there differences in quality of life, self-compassion, flourishing, self-efficacy, social support, habit formation, and fruit /vegetable consumption
Read more
Participants will:
- Wear a Fitbit
- Complete surveys
- Participate in 30 minute weekly virtual meetings (FitEx groups only)
- Receive weekly newsletters (FitEx groups only)
Read the detailed description
The purpose of this pilot study is to evaluate the initial efficacy of FitEx, a physical activity tracking and promotion program, and FitEx+yoga for endometrial cancer survivors (ECS), with focus on improvement of moderate-vigorous physical activity (MVPA) at the completion of the 8-week program. Specifically, this project will recruit early stage ECS with obesity to be randomized to 1 of 3 conditions: 1) usual care, 2) FitEx, 3) FitEx+yoga. ECS in either intervention condition will each select ~3 friends or family members to be their support members (minimum 2 and maximum 5). All ECS will receive a Fitbit to track their MVPA. We will then compare secondary ECS outcome measures between intervention and control groups including quality of life, self-compassion, flourishing, self-efficacy, social support, habit formation and fruit/vegetable consumption. Additionally, support team member MVPA (via Fitbit) and secondary outcomes will be compared. We will also explore long-term MPVA and secondary outcomes in all groups at 6 months.
- Conditions
- Endometrial Cancer, Obesity, Sedentary Behavior, Quality of Life, Survivorship
- Being tested
- Self-monitoring, Group-dynamics, Weekly virtual sessions- Standard, Newsletters- Standard, Newsletters- Yoga
- Medical subject headings
- Endometrial Neoplasms, Obesity, Sedentary Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Self-monitoringBehavioural
Tracking physical activity and fruit/vegetable intake.
Group-dynamicsBehavioural
Survivors act as team captains, facilitating interactions between themselves and their support team members and providing goal directed feedback.
Weekly virtual sessions- StandardBehavioural
Weekly 30 minute virtual sessions include support group/team building sessions and 15 minutes of physical activity.
Newsletters- StandardBehavioural
Weekly newsletters support attainment of physical activity and nutrition goals.
Newsletters- YogaBehavioural
Weekly newsletters support attainment of physical activity and nutrition goals, while including mindfulness principles.
Weekly virtual sessions- YogaBehavioural
Weekly 30 minute virtual sessions include support group/team building sessions and 15 minutes of yoga.
| Study group | Role | What they receive |
|---|---|---|
| Usual care | No intervention | Endometrial cancer survivors will receive standard survivorship care including a one-time educational newsletter about survivorship physical activity and nutrition recommendations. Fitbits will be given to track physical activity. |
| FitEx-ECS | Experimental | Endometrial cancer survivors and their support team members (as a group of one survivor and their team) will complete the FitEx-ECS intervention program, with a focus on walking. Fitbits will be given to track physical activity. Receives: Behavioral: Self-monitoring; Behavioral: Group-dynamics; Behavioral: Weekly virtual sessions- Standard; Behavioral: Newsletters- Standard |
| FitEx-ECS+ Yoga | Experimental | Endometrial cancer survivors and their support team members (as a group of one survivor and their team) will complete the FitEx-ECS+yoga intervention program, with a focus on postures, breathwork, and mindfulness. Fitbits will be given to track physical activity. Receives: Behavioral: Self-monitoring; Behavioral: Group-dynamics; Behavioral: Newsletters- Yoga; Behavioral: Weekly virtual sessions- Yoga |
What is being measured
The primary outcome is the main question the study is designed to answer.
Moderate to Vigorous Physical Activity of Endometrial Cancer Survivors
Among survivors, compare changes in objective moderate-vigorous physical activity (MVPA) obtained from FitBits (continuous tracking) between intervention groups and usual care (FitEx-ECS vs. control and FitEx-ECS+yoga vs. control)
Measured: Change from baseline to 8 weeks (post-intervention)
Secondary outcomes (17)
Quality of Life- Survivors
Examine the change in quality of life (measured via Functional Assessment of Cancer Therapy - Endometrial (FACT-En)) between intervention and usual care conditions (FitEx-ECS versus control and FitEx-ECS+yoga versus control).
Scoring: physical well-being (0-28), social well-being (0-28), emotional well-being (0-28), functional well-being (0-28), endometrial cancer sub-scale (0-64); higher scores indicate better quality of life
Measured: Change from baseline to 8 weeks (post-intervention)
Quality of Life Maintenance- Survivors
Examine the change in quality of life (measured via Functional Assessment of Cancer Therapy - Endometrial) between intervention and usual care conditions (FitEx-ECS versus control and FitEx-ECS+yoga versus control).
Scoring: physical well-being (0-28), social well-being (0-28), emotional well-being (0-28), functional well-being (0-28), endometrial cancer sub-scale (0-64); higher scores indicate better quality of life
Measured: Change from 8 weeks to 6 months (post-intervention)
Servings of Daily Fruits and Vegetables Maintenance- Survivors
Examine the change in fruit/vegetable intake (measured via Behavioral Risk Factor Surveillance System (BRFSS F/V) survey) between intervention and usual care conditions (FitEx-ECS versus control and FitEx-ECS+yoga versus control).
Measured: Change from 8 weeks to 6 months (post-intervention)
Servings of Daily Fruits and Vegetables- Survivors
Examine the change in fruit/vegetable intake (measured via Behavioral Risk Factor Surveillance System (BRFSS F/V) survey) between intervention and usual care conditions (FitEx-ECS versus control and FitEx-ECS+yoga versus control).
Measured: Change from baseline to 8 weeks (post-intervention)
Flourishing- Survivors
Examine the change in flourishing (measured via The Flourishing Index) between intervention and usual care conditions (FitEx-ECS versus control and FitEx-ECS+yoga versus control).
Scoring: 0-10, with higher scores indication more satisfaction/flourishing
Measured: Change from baseline to 8 weeks (post-intervention)
Flourishing Maintenance- Survivors
Examine the change in flourishing (measured via The Flourishing Index) between intervention and usual care conditions (FitEx-ECS versus control and FitEx-ECS+yoga versus control).
Scoring: 0-10, with higher scores indication more satisfaction/flourishing
Measured: Change from 8 weeks to 6 months (post-intervention)
Yoga Self-Efficacy- Survivors
Examine the change in yoga self-efficacy (measured via the Yoga Self-Efficacy Scale) between intervention and usual care conditions (FitEx-ECS versus control and FitEx-ECS+yoga versus control).
Scoring: (12-108) higher scores indicate higher efficacy for yoga
Measured: Change from baseline to 8 weeks (post-intervention)
Yoga Self-Efficacy Maintenance- Survivors
Examine the change in yoga self-efficacy (measured via the Yoga Self-Efficacy Scale) between intervention and usual care conditions (FitEx-ECS versus control and FitEx-ECS+yoga versus control).
Scoring: (12-108) higher scores indicate higher efficacy for yoga
Measured: Change from 8 weeks to 6 months (post-intervention)
Social Support- Survivors
Examine the change in social support (measured via the Sallis Social Support for Exercise Survey) between intervention and usual care conditions (FitEx-ECS versus control and FitEx-ECS+yoga versus control).
Scoring: higher numbers indicate more support
Measured: Change from baseline to 8 weeks (post-intervention)
Social Support Maintenance- Survivors
Examine the change in social support (measured via the Sallis Social Support for Exercise Survey) between intervention and usual care conditions (FitEx-ECS versus control and FitEx-ECS+yoga versus control).
Scoring: higher numbers indicate more support
Measured: Change from 8 weeks to 6 months (post-intervention)
Self-compassion- Survivors
Examine the change in self-compassion (measured via the Neff 12 item Self-Compassion Scale Short Form (SCS-SF) ) between intervention and usual care conditions (FitEx-ECS versus control and FitEx-ECS+yoga versus control).
Scoring: (1, 5) with higher scores indicating more self-compassion
Measured: Change from baseline to 8 weeks (post-intervention)
Self-compassion Maintenance- Survivors
Examine the change in self-compassion (measured via the Neff 12 item Self-Compassion Scale Short Form (SCS-SF) ) between intervention and usual care conditions (FitEx-ECS versus control and FitEx-ECS+yoga versus control).
Scoring: (1, 5) with higher scores indicating more self-compassion
Measured: Change from 8 weeks to 6 months (post-intervention)
Habit Formation- Survivors
Examine the change in habit formation around exercise (measured via Self-Reported Behavior Automaticity Index) between intervention and usual care conditions (FitEx-ECS versus control and FitEx-ECS+yoga versus control).
Scoring (1,7), higher scores indicate more automaticity/habit formation
Measured: Change from baseline to 8 weeks (post-intervention)
Habit Formation Maintenance- Survivors
Examine the change in habit formation around exercise (measured via Self-Reported Behavior Automaticity Index) between intervention and usual care conditions (FitEx-ECS versus control and FitEx-ECS+yoga versus control).
Scoring (1,7), higher scores indicate more automaticity/habit formation
Measured: Change from 8 weeks to 6 months (post-intervention)
Physical Activity Level (Active or Insufficiently Active) Maintenance- Survivors
Examine the change in national physical activity goal attainment (measured via The Stanford Leisure-Time Activity Categorical Item (L-Cat)) between intervention and usual care conditions (FitEx-ECS versus control and FitEx-ECS+yoga versus control).
Measured: Change from 8 weeks to 6 months (post-intervention)
Physical Activity Level (Active or Insufficiently Active)- Survivors
Examine the change in national physical activity goal attainment (measured via The Stanford Leisure-Time Activity Categorical Item (L-Cat)) between intervention and usual care conditions (FitEx-ECS versus control and FitEx-ECS+yoga versus control).
Scoring: responses are categorical
Measured: Change from baseline to 8 weeks (post-intervention)
Moderate to Vigorous Physical Activity of Endometrial Cancer Survivors- Maintenance
Among survivors, compare changes in objective moderate-vigorous physical activity (MVPA) obtained from FitBits between intervention groups and usual care (FitEx-ECS vs. control and FitEx-ECS+yoga vs. control)
Measured: Change from 8 weeks to 6 months (post-intervention)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Feb 2023
- Study start1 Feb 2023
- Primary completion30 Nov 2023
- Study completion20 Jun 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Other trials for Endometrial CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 111 participants (actual)
Sponsor and investigators
- Lead sponsor
- Carilion Clinic
- Sponsor type
- University, hospital or other
- Collaborators
- National Institutes of Health (NIH), National Center for Advancing Translational Sciences (NCATS), Virginia Polytechnic Institute and State University
- Responsible party
- Principal investigator, Shannon Armbruster, Carilion Clinic
- Investigators
- Shannon Armbruster, MD MPH, Principal investigator, Carilion Clinic
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05737745
- Sponsor's protocol ID
- IRB-22-1727
- Other IDs
- UL1TR003015
- Status last verified
- Apr 2025
- First submitted
- 1 Feb 2023
- Last updated
- 9 May 2025
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 May 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Initial Efficacy of FitEx for Endometrial Cancer Survivors: A Pilot Randomized Controlled Trial of a Walking Promotion Program With or Without Yoga
- ClinicalTrials.gov ID
- NCT05737745
- Acronym / sponsor ID
- IRB-22-1727
- Conditions
- Endometrial Cancer, Obesity, Sedentary Behavior, Quality of Life, Survivorship
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 111 participants (actual)
- Lead sponsor
- Carilion ClinicUniversity, hospital or other
- Collaborators
- National Institutes of Health (NIH), National Center for Advancing Translational Sciences (NCATS), Virginia Polytechnic Institute and State University
- Study start
- 1 Feb 2023 (actual)
- Primary completion
- 30 Nov 2023 (actual)
- Study completion
- 20 Jun 2024 (actual)
- First posted
- 21 Feb 2023 (actual)
- Results
- Posted 9 May 2025
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to compare physical activity outcomes between endometrial cancer survivors randomized to 1 of 3 conditions: 1) usual care, 2) FitEx, 3) FitEx+yoga. Survivors randomized to FitEx groups will recruit ~3 support team members to complete the intervention with them. The main question[s] it aims to answer are:
- Do FitEx groups undertake more physical activity than the usual care group?
- Are there differences in quality of life, self-compassion, flourishing, self-efficacy, social support, habit formation, and fruit /vegetable consumption
Participants will:
- Wear a Fitbit
- Complete surveys
- Participate in 30 minute weekly virtual meetings (FitEx groups only)
- Receive weekly newsletters (FitEx groups only)
Detailed description
The purpose of this pilot study is to evaluate the initial efficacy of FitEx, a physical activity tracking and promotion program, and FitEx+yoga for endometrial cancer survivors (ECS), with focus on improvement of moderate-vigorous physical activity (MVPA) at the completion of the 8-week program. Specifically, this project will recruit early stage ECS with obesity to be randomized to 1 of 3 conditions: 1) usual care, 2) FitEx, 3) FitEx+yoga. ECS in either intervention condition will each select ~3 friends or family members to be their support members (minimum 2 and maximum 5). All ECS will receive a Fitbit to track their MVPA. We will then compare secondary ECS outcome measures between intervention and control groups including quality of life, self-compassion, flourishing, self-efficacy, social support, habit formation and fruit/vegetable consumption. Additionally, support team member MVPA (via Fitbit) and secondary outcomes will be compared. We will also explore long-term MPVA and secondary outcomes in all groups at 6 months.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Usual care | No intervention | –Endometrial cancer survivors will receive standard survivorship care including a one-time educational newsletter about survivorship physical activity and nutrition recommendations. Fitbits will be given to track physical activity. |
| FitEx-ECS | Experimental | Behavioral: Self-monitoring, Behavioral: Group-dynamics, Behavioral: Weekly virtual sessions- Standard, Behavioral: Newsletters- StandardEndometrial cancer survivors and their support team members (as a group of one survivor and their team) will complete the FitEx-ECS intervention program, with a focus on walking. Fitbits will be given to track physical activity. |
| FitEx-ECS+ Yoga | Experimental | Behavioral: Self-monitoring, Behavioral: Group-dynamics, Behavioral: Newsletters- Yoga, Behavioral: Weekly virtual sessions- YogaEndometrial cancer survivors and their support team members (as a group of one survivor and their team) will complete the FitEx-ECS+yoga intervention program, with a focus on postures, breathwork, and mindfulness. Fitbits will be given to track physical activity. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (16 listed)
- SURIVIVOR
- Diagnosed with early stage (I-II) endometrial cancer, any histology
- Received cancer care at Carilion Clinic after 1/1/2010
- At least 18 years of age
- Have adequate comprehension (reading and writing) of the English language
Key exclusion criteria (4 listed)
- SURVIVOR
- Recurrent endometrial cancer
- Meeting physical activity guidelines set forth by the American Cancer Society at screening (greater than 150 minutes/week of moderate physical activity, or greater than 75 minutes/week of vigorous physical activity)
- SUPPORT TEAM: Have functional limitations requiring a walker, wheelchair, scooter, or other walking aid which limits their capacity to engage in the intervention safely
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Self-monitoringTracking physical activity and fruit/vegetable intake. | Behavioural | FitEx-ECS, FitEx-ECS+ Yoga |
| Group-dynamicsSurvivors act as team captains, facilitating interactions between themselves and their support team members and providing goal directed feedback. | Behavioural | FitEx-ECS, FitEx-ECS+ Yoga |
| Weekly virtual sessions- StandardWeekly 30 minute virtual sessions include support group/team building sessions and 15 minutes of physical activity. | Behavioural | FitEx-ECS |
| Newsletters- StandardWeekly newsletters support attainment of physical activity and nutrition goals. | Behavioural | FitEx-ECS |
| Newsletters- YogaWeekly newsletters support attainment of physical activity and nutrition goals, while including mindfulness principles. | Behavioural | FitEx-ECS+ Yoga |
| Weekly virtual sessions- YogaWeekly 30 minute virtual sessions include support group/team building sessions and 15 minutes of yoga. | Behavioural | FitEx-ECS+ Yoga |
Primary outcome
Moderate to Vigorous Physical Activity of Endometrial Cancer Survivors
Time frame: Change from baseline to 8 weeks (post-intervention)
Among survivors, compare changes in objective moderate-vigorous physical activity (MVPA) obtained from FitBits (continuous tracking) between intervention groups and usual care (FitEx-ECS vs. control and FitEx-ECS+yoga vs. control)
17 secondary outcomes
Quality of Life- Survivors
Time frame: Change from baseline to 8 weeks (post-intervention)
Quality of Life Maintenance- Survivors
Time frame: Change from 8 weeks to 6 months (post-intervention)
Servings of Daily Fruits and Vegetables Maintenance- Survivors
Time frame: Change from 8 weeks to 6 months (post-intervention)
Servings of Daily Fruits and Vegetables- Survivors
Time frame: Change from baseline to 8 weeks (post-intervention)
Flourishing- Survivors
Time frame: Change from baseline to 8 weeks (post-intervention)
Flourishing Maintenance- Survivors
Time frame: Change from 8 weeks to 6 months (post-intervention)
Yoga Self-Efficacy- Survivors
Time frame: Change from baseline to 8 weeks (post-intervention)
Yoga Self-Efficacy Maintenance- Survivors
Time frame: Change from 8 weeks to 6 months (post-intervention)
Social Support- Survivors
Time frame: Change from baseline to 8 weeks (post-intervention)
Social Support Maintenance- Survivors
Time frame: Change from 8 weeks to 6 months (post-intervention)
Self-compassion- Survivors
Time frame: Change from baseline to 8 weeks (post-intervention)
Self-compassion Maintenance- Survivors
Time frame: Change from 8 weeks to 6 months (post-intervention)
Habit Formation- Survivors
Time frame: Change from baseline to 8 weeks (post-intervention)
Habit Formation Maintenance- Survivors
Time frame: Change from 8 weeks to 6 months (post-intervention)
Physical Activity Level (Active or Insufficiently Active) Maintenance- Survivors
Time frame: Change from 8 weeks to 6 months (post-intervention)
Physical Activity Level (Active or Insufficiently Active)- Survivors
Time frame: Change from baseline to 8 weeks (post-intervention)
Moderate to Vigorous Physical Activity of Endometrial Cancer Survivors- Maintenance
Time frame: Change from 8 weeks to 6 months (post-intervention)
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 May 2025.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
- Individual participant dataSharing planned: No
Related trials for Endometrial Cancer
Recruiting
Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
Gynaecological Cancers, Ovarian Cancer
Active, not recruitingPhase 3
Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line
Endometrial Cancer
RecruitingPhase 3
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
RecruitingPhase 2
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
Advanced Anal Carcinoma, Advanced Biliary Tract Carcinoma
RecruitingPhase 3
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Shannon Armbruster, MD MPH principal investigator
Carilion Clinic
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Self-monitoring, Group-dynamics and Weekly virtual sessions- Standard in people with Endometrial Cancer and Obesity, run by Carilion Clinic at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 16 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 May 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 9 May 2025). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Moderate to Vigorous Physical Activity of Endometrial Cancer Survivors (time frame: Change from baseline to 8 weeks (post-intervention)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 May 2025.